News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Plenge Robert M
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
4
| Plenge Robert M (EVP, Chief Research Officer) has filed a Form 4 on BRISTOL MYERS SQUIBB CO
Txns:
| Sold 732 shares
@ $61.14, valued at
$44.8k
|
|
07/05/2023 |
3
| Plenge Robert M (EVP, Chief Research Officer) has filed a Form 3 on BRISTOL MYERS SQUIBB CO |
09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2020 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 18,900 options to buy
@ $15.33, valued at
$289.7k
|
|
06/19/2019 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 18,900 options to buy
@ $10.2, valued at
$192.8k
|
|
04/11/2019 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 37,800 options to buy
@ $12.36, valued at
$467.2k
|
|
04/11/2019 |
3
| Plenge Robert M (Director) has filed a Form 3 on Translate Bio, Inc. |
|
|